05/12/2025
8:00 AM | BioXcel Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/12/2025
6:15 AM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/01/2025
6:23 PM | BioXcel Therapeutics (Issuer)
MACK DAVID J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/04/2025
3:16 PM | BioXcel Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
04/03/2025
3:32 PM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/03/2025
3:30 PM | BioXcel Therapeutics (Filer)
| Form 424B5 | |
04/01/2025
5:08 PM | BioXcel Therapeutics (Issuer)
O'Neill Vincent (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2025
5:02 PM | BioXcel Therapeutics (Issuer)
MACK DAVID J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2025
5:02 PM | BioXcel Therapeutics (Issuer)
Yocca Frank (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2025
5:04 PM | BioXcel Therapeutics (Issuer)
Rodriguez Javier (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2025
5:06 PM | BioXcel Therapeutics (Issuer)
Wiley Matthew T. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for BTAI and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for BioXcel Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
04/01/2025
5:07 PM | BioXcel Therapeutics (Issuer)
Steinhart Richard I (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2025
5:08 PM | BioXcel Therapeutics (Issuer)
Mehta Vimal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2025
4:00 PM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/21/2025
6:00 AM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/17/2025
5:35 PM | BioXcel Therapeutics (Issuer)
Mehta Vimal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/17/2025
5:36 PM | BioXcel Therapeutics (Issuer)
Yocca Frank (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/17/2025
5:37 PM | BioXcel Therapeutics (Issuer)
Rodriguez Javier (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/17/2025
5:38 PM | BioXcel Therapeutics (Issuer)
Steinhart Richard I (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
8:21 PM | BioXcel Therapeutics (Issuer)
MACK DAVID J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
7:51 AM | BioXcel Therapeutics (Filer)
| Form 424B5 | |
03/03/2025
7:42 AM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2025
4:27 PM | ARMISTICE CAPITAL, LLC (Filed by)
BioXcel Therapeutics (Subject)
| Form SCHEDULE 13G | |
02/06/2025
7:44 AM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/04/2025
4:28 PM | BioXcel Therapeutics (Issuer)
MACK DAVID J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2025
3:15 PM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/20/2025
11:15 PM | BioXcel Therapeutics (Filer)
| Form EFFECT | |
01/16/2025
7:00 AM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/16/2025
7:03 AM | BioXcel Therapeutics (Issuer)
Patni Rajiv (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/16/2025
7:04 AM | BioXcel Therapeutics (Issuer)
Patni Rajiv (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2025
7:00 PM | BioXcel Therapeutics (Issuer)
Steinhart Richard I (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2025
7:01 PM | BioXcel Therapeutics (Issuer)
Yocca Frank (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2025
7:03 PM | BioXcel Therapeutics (Issuer)
Mehta Vimal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2025
3:45 PM | BioXcel Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
01/08/2025
6:45 AM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/30/2024
3:15 PM | BioXcel Therapeutics (Filer)
| Form DEF 14A | |
12/18/2024
7:19 PM | BioXcel Therapeutics (Subject)
Oaktree Capital Group Holdings GP, LLC (Filed by)
| Form SCHEDULE 13G | |
12/18/2024
4:16 PM | BioXcel Therapeutics (Filer)
| Form PRE 14A | |
12/18/2024
4:20 PM | BioXcel Therapeutics (Subject)
Qatar Investment Authority (Filed by)
| Form SCHEDULE 13G | |
12/17/2024
5:10 PM | BioXcel Therapeutics (Issuer)
O'Neill Vincent (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
5:03 PM | BioXcel Therapeutics (Issuer)
Yocca Frank (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Vladimir Lenin was right… (Ad) The Magnificent 7 could be in for a world of pain…
And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock.
The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on.
It’s called The Final Frontier. Including the name of the #1 company to buy. |
12/17/2024
5:04 PM | BioXcel Therapeutics (Issuer)
Rodriguez Javier (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
5:06 PM | BioXcel Therapeutics (Issuer)
Steinhart Richard I (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
5:08 PM | BioXcel Therapeutics (Issuer)
Mehta Vimal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2024
3:21 PM | BioXcel Therapeutics (Subject)
O'Neill Vincent (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/16/2024
2:33 PM | BioXcel Therapeutics (Subject)
Steinhart Richard I (Reporting)
| Form 144/A | |
12/16/2024
2:23 PM | BioXcel Therapeutics (Subject)
Yocca Frank (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/16/2024
2:00 PM | BioXcel Therapeutics (Subject)
Steinhart Richard I (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/16/2024
1:10 PM | BioXcel Therapeutics (Subject)
Mehta Vimal (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/25/2024
3:05 PM | BioXcel Therapeutics (Issuer)
MACK DAVID J. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/25/2024
3:06 PM | BioXcel Therapeutics (Issuer)
MACK DAVID J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/25/2024
5:00 AM | BioXcel Therapeutics (Filer)
| Form 424B5 | |
11/21/2024
3:43 PM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/21/2024
3:46 PM | BioXcel Therapeutics (Filer)
| Form 424B5 | |
11/14/2024
8:10 AM | BioXcel Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/14/2024
6:00 AM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/09/2024
3:08 PM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/03/2024
8:53 PM | BioXcel Therapeutics (Issuer)
O'Neill Vincent (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
8:54 PM | BioXcel Therapeutics (Issuer)
Steinhart Richard I (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
8:54 PM | BioXcel Therapeutics (Issuer)
Yocca Frank (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
8:55 PM | BioXcel Therapeutics (Issuer)
Rodriguez Javier (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
8:55 PM | BioXcel Therapeutics (Issuer)
Wiley Matthew T. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
3:33 PM | BioXcel Therapeutics (Subject)
Wiley Matthew T. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/03/2024
3:40 PM | BioXcel Therapeutics (Subject)
Rodriguez Javier (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/03/2024
3:17 PM | BioXcel Therapeutics (Subject)
Yocca Frank (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/19/2024
6:00 AM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/17/2024
6:17 PM | BioXcel Therapeutics (Issuer)
Wiley Matthew T. (Reporting)
| Form 4/A | |
09/17/2024
6:18 PM | BioXcel Therapeutics (Issuer)
Wiley Matthew T. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2024
6:19 PM | BioXcel Therapeutics (Issuer)
O'Neill Vincent (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2024
6:20 PM | BioXcel Therapeutics (Issuer)
Rodriguez Javier (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2024
6:21 PM | BioXcel Therapeutics (Issuer)
Steinhart Richard I (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2024
6:21 PM | BioXcel Therapeutics (Issuer)
Mehta Vimal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2024
6:23 PM | BioXcel Therapeutics (Issuer)
Yocca Frank (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2024
4:42 PM | BioXcel Therapeutics (Subject)
Yocca Frank (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/16/2024
4:26 PM | BioXcel Therapeutics (Subject)
Wiley Matthew T. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/16/2024
4:16 PM | BioXcel Therapeutics (Subject)
Rodriguez Javier (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/16/2024
2:48 PM | BioXcel Therapeutics (Subject)
O'Neill Vincent (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/16/2024
1:58 PM | BioXcel Therapeutics (Subject)
Steinhart Richard I (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/16/2024
12:23 PM | BioXcel Therapeutics (Subject)
Mehta Vimal (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/10/2024
9:47 AM | BioXcel Therapeutics (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
09/09/2024
3:15 PM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/05/2024
6:16 AM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/06/2024
6:05 AM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/17/2024
3:41 PM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/16/2024
6:00 AM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/25/2024
6:05 AM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/18/2024
8:22 PM | BioXcel Therapeutics (Issuer)
O'Neill Vincent (Reporting)
| Form 4/A | |
06/18/2024
8:24 PM | BioXcel Therapeutics (Issuer)
Mehta Vimal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
8:25 PM | BioXcel Therapeutics (Issuer)
O'Neill Vincent (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
8:25 PM | BioXcel Therapeutics (Issuer)
Rodriguez Javier (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
8:26 PM | BioXcel Therapeutics (Issuer)
Steinhart Richard I (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Now I look stupid. Real stupid... (Ad) I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was.
Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.  Here’s the full story for you. |
06/18/2024
8:26 PM | BioXcel Therapeutics (Issuer)
Wiley Matthew T. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
8:27 PM | BioXcel Therapeutics (Issuer)
Yocca Frank (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
2:13 PM | BioXcel Therapeutics (Subject)
Rodriguez Javier (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/17/2024
1:34 PM | BioXcel Therapeutics (Subject)
Wiley Matthew T. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/17/2024
1:09 PM | BioXcel Therapeutics (Subject)
O'Neill Vincent (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/17/2024
12:46 PM | BioXcel Therapeutics (Subject)
Yocca Frank (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/17/2024
12:04 PM | BioXcel Therapeutics (Subject)
Mehta Vimal (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/17/2024
12:21 PM | BioXcel Therapeutics (Subject)
Steinhart Richard I (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/11/2024
6:00 PM | BioXcel Therapeutics (Issuer)
Bray June (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Buy BTAI Stock Free BTAI Stock Alerts